RecruitingNot ApplicableNCT06104774
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
Vice Superintendent
Sponsor
China Medical University Hospital
Enrollment
200 participants
Start Date
Oct 20, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
To explore the effect of a family-centered, eight-week, progressive sit-to-stand Tai Chi exercise on lung function and mental health in patients after thoracoscopic surgery\_
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Hospitalized to receive thoracoscopic lobectomy, wedge/partial resection, lobectomy, or sleeve resection.
- American Society of Anesthesiologists (ASA) physiological status classification I-II (ASA, 2019).ASA Physical Status Class I: A healthy person who is healthy and does not smoke or drink.ASA physical status class II: People with mild chronic diseases but no substantial functional limitations.
- Those who can walk on their own without any impairment in limb movement.
- Able to communicate in Chinese or Taiwanese.
Exclusion Criteria5
- Individuals requiring chemotherapy and radiation therapy for malignant tumors.
- Those who have practiced Tai Chi, Qigong, external elixir exercises, or pulmonary exercises within the past year.
- Anticipating hospitalization or surgical treatment within the next three months.
- Individuals with musculoskeletal or peripheral vascular diseases.
- Individuals with visual impairment, intellectual disabilities, or memory loss.
Interventions
BEHAVIORALTai Chi Exercise
The experimental group will receive Tai Chi exercise and routine treatment after the operation, and after discharge from the hospital, they will perform Tai Chi exercise three times a week, 50 minutes each time, for a total of eight weeks after discharge.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06104774
Related Trials
Erector Spinae Block for Thoracic Surgery
NCT055217891 location
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
NCT067587001 location
Real World Registry for Use of the Ion Endoluminal System
NCT0600444016 locations
Early Intervention Strategies for Lung Cancer
NCT069889431 location
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
NCT061779251 location